Findings

What do systematic reviews say?

4,710 questions · 14,842 findings · 1,394 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2,880 · 19.4%GRADE not reported 1,413 · 9.5%Very low 3,103 · 20.9%Low 3,870 · 26.1%Moderate 2,663 · 17.9%High 913 · 6.2%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Ravulizumab vs placebo or alternative treatment

Requirement for KRT · adults with aHUS

1 finding from 1 review

Interventions for atypical haemolytic uraemic syndrome 2021 · Cochrane Headline outcomes only
no estimate extracted
56 participants
Very low

Bethanechol vs placebo

Rate of spontaneous voiding recovery 1 week after surgery

The review found no eligible studies for this question.

1 finding from 1 review

Postoperative interventions for preventing bladder dysfunction after radical hysterectomy in women with early‐stage… 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Bethanechol vs placebo

QoL

The review found no eligible studies for this question.

1 finding from 1 review

Postoperative interventions for preventing bladder dysfunction after radical hysterectomy in women with early‐stage… 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Bethanechol vs placebo

Time after surgery to post‐void residual volume of urine ≤ 50 mL (days)

The review found no eligible studies for this question.

1 finding from 1 review

Postoperative interventions for preventing bladder dysfunction after radical hysterectomy in women with early‐stage… 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Bethanechol vs placebo

Adverse events

The review found no eligible studies for this question.

1 finding from 1 review

Postoperative interventions for preventing bladder dysfunction after radical hysterectomy in women with early‐stage… 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Bethanechol vs placebo

Post‐void residual urine volume (mL) at 1 month after surgery

1 finding from 1 review

Postoperative interventions for preventing bladder dysfunction after radical hysterectomy in women with early‐stage… 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
Very low

Bethanechol vs placebo

Urinary tract infection

The review found no eligible studies for this question.

1 finding from 1 review

Postoperative interventions for preventing bladder dysfunction after radical hysterectomy in women with early‐stage… 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Bethanechol vs placebo

Subjective urinary symptoms

The review found no eligible studies for this question.

1 finding from 1 review

Postoperative interventions for preventing bladder dysfunction after radical hysterectomy in women with early‐stage… 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Fludrocortisone vs placebo

Blood pressure · people with diabetes and orthostatic hypotension

1 finding from 1 review

Fludrocortisone for orthostatic hypotension 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 6 participants
Very low

Fludrocortisone vs placebo

Orthostatic symptoms · people with diabetes and orthostatic hypotension

1 finding from 1 review

Fludrocortisone for orthostatic hypotension 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 6 participants
Very low

Fludrocortisone vs placebo

Frequency and severity of postural lightheadedness · people with diabetes and orthostatic hypotension

1 finding from 1 review

Fludrocortisone for orthostatic hypotension 2021 · Cochrane Headline outcomes only
no estimate extracted
0 participants
GRADE not reported

Fludrocortisone vs placebo

Frequency of syncope · people with diabetes and orthostatic hypotension

1 finding from 1 review

Fludrocortisone for orthostatic hypotension 2021 · Cochrane Headline outcomes only
no estimate extracted
0 participants
GRADE not reported

Fludrocortisone vs placebo

Quality of life · people with diabetes and orthostatic hypotension

1 finding from 1 review

Fludrocortisone for orthostatic hypotension 2021 · Cochrane Headline outcomes only
no estimate extracted
0 participants
GRADE not reported

Fludrocortisone vs placebo

Serious or severe adverse events · people with diabetes and orthostatic hypotension

1 finding from 1 review

Fludrocortisone for orthostatic hypotension 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 6 participants
Very low

Nifedipine vs placebo

Relief of pain · primary dysmenorrhoea

It is very uncertain whether nifedipine changes pain relief (any) compared with placebo (very low certainty).

1 finding from 1 review

Nifedipine for primary dysmenorrhoea 2021 · Cochrane Headline outcomes only
OR 9.04 [2.61, 31.31]
2 studies · 66 participants
Very low

Nifedipine vs placebo

Good or excellent pain relief · primary dysmenorrhoea

It is very uncertain whether nifedipine changes good or excellent pain relief compared with placebo (very low certainty).

1 finding from 1 review

Nifedipine for primary dysmenorrhoea 2021 · Cochrane Headline outcomes only
OR 43.78 [5.34, 359.01]
2 studies · 66 participants
Very low

Nifedipine vs placebo

Health‐related quality of life · primary dysmenorrhoea

The review found no eligible studies for this question.

1 finding from 1 review

Nifedipine for primary dysmenorrhoea 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Nifedipine vs placebo

Total adverse effects · primary dysmenorrhoea

It is very uncertain whether nifedipine changes total adverse effects compared with placebo (very low certainty).

1 finding from 1 review

Nifedipine for primary dysmenorrhoea 2021 · Cochrane Headline outcomes only
OR 0.94 [0.08, 10.9]
1 study · 24 participants
Very low

Nifedipine vs placebo

Bothersome adverse effects · primary dysmenorrhoea

It is very uncertain whether nifedipine changes bothersome adverse effects compared with placebo (very low certainty).

1 finding from 1 review

Nifedipine for primary dysmenorrhoea 2021 · Cochrane Headline outcomes only
OR 0.54 [0.07, 4.2]
1 study · 24 participants
Very low

Nifedipine vs placebo

Requirement for additional medication · primary dysmenorrhoea

It is very uncertain whether nifedipine changes requirement for additional medication compared with placebo (very low certainty).

1 finding from 1 review

Nifedipine for primary dysmenorrhoea 2021 · Cochrane Headline outcomes only
OR 0.07 [0.02, 0.32]
1 study · 42 participants
Very low